Paper34616307
The Transient Receptor Potential Vanilloid 4 Channel and Cardiovascular Disease Risk Factors.
Goto K and 1 other. Front Physiol, 2021. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. The Transient Receptor Potential Vanilloid 4 Channel and Cardiovascular Disease Risk Factors. Papers, record 34616307. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34616307
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Transient Receptor Potential Vanilloid 4 Channel and Cardiovascular Disease Risk Factors.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References61
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27872234 | Downregulation of Endothelial Transient Receptor Potential Vanilloid Type 4 Channel and Small-Conductance of Ca2+-Activated K+ Channels Underpins Impaired Endothelium-Dependent Hyperpolarization in Hypertension. | Hypertension | 2017 | https://conductscience.org/library/papers/27872234 | PubMed |
| 2 | 17335855 | Disruption of endothelial caveolae is associated with impairment of both NO- as well as EDHF in acetylcholine-induced relaxation depending on their relative contribution in different vascular beds. | Life Sci | 2007 | https://conductscience.org/library/papers/17335855 | PubMed |
| 3 | 33723357 | High intraluminal pressure promotes vascular inflammation via caveolin-1. | Sci Rep | 2021 | https://conductscience.org/library/papers/33723357 | PubMed |
| 4 | 22476229 | Upregulation of endothelium-derived hyperpolarizing factor compensates for the loss of nitric oxide in mesenteric arteries of Dahl salt-sensitive hypertensive rats. | Hypertens Res | 2012 | https://conductscience.org/library/papers/22476229 | PubMed |
| 5 | 19359599 | TRPV4 channels mediate cyclic strain-induced endothelial cell reorientation through integrin-to-integrin signaling. | Circ Res | 2009 | https://conductscience.org/library/papers/19359599 | PubMed |
| 6 | 31735085 | Activation of Transient Receptor Potential Channel Vanilloid 4 by DPP-4 (Dipeptidyl Peptidase-4) Inhibitor Vildagliptin Protects Against Diabetic Endothelial Dysfunction. | Hypertension | 2020 | https://conductscience.org/library/papers/31735085 | PubMed |
| 7 | 21880870 | Opening of small and intermediate calcium-activated potassium channels induces relaxation mainly mediated by nitric-oxide release in large arteries and endothelium-derived hyperpolarizing factor in small arteries from rat. | J Pharmacol Exp Ther | 2011 | https://conductscience.org/library/papers/21880870 | PubMed |
| 8 | 28472069 | Detection of TRPV4 channel current-like activity in Fawn Hooded hypertensive (FHH) rat cerebral arterial muscle cells. | PLoS One | 2017 | https://conductscience.org/library/papers/28472069 | PubMed |
| 9 | 32402646 | Endothelial TRPV4 channels and vasodilator reactivity. | Curr Top Membr | 2020 | https://conductscience.org/library/papers/32402646 | PubMed |
| 10 | 31370156 | Endothelium-Dependent Hyperpolarization (EDH) in Diabetes: Mechanistic Insights and Therapeutic Implications. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31370156 | PubMed |
| 11 | 32008372 | Local Peroxynitrite Impairs Endothelial Transient Receptor Potential Vanilloid 4 Channels and Elevates Blood Pressure in Obesity. | Circulation | 2020 | https://conductscience.org/library/papers/32008372 | PubMed |
| 12 | 26706498 | Endothelial dysfunction and vascular disease - a 30th anniversary update. | Acta Physiol (Oxf) | 2017 | https://conductscience.org/library/papers/26706498 | PubMed |
| 13 | 28433656 | Impaired endothelium-derived hyperpolarization-type relaxation in superior mesenteric arteries isolated from female Otsuka Long-Evans Tokushima Fatty rats. | Eur J Pharmacol | 2017 | https://conductscience.org/library/papers/28433656 | PubMed |
| 14 | 23107877 | TRPV4 and the regulation of vascular tone. | J Cardiovasc Pharmacol | 2013 | https://conductscience.org/library/papers/23107877 | PubMed |
| 15 | 22140047 | Activation of endothelial TRPV4 channels mediates flow-induced dilation in human coronary arterioles: role of Ca2+ entry and mitochondrial ROS signaling. | Am J Physiol Heart Circ Physiol | 2012 | https://conductscience.org/library/papers/22140047 | PubMed |
| 16 | 18344620 | Relationship between oxidative stress and essential hypertension. | Hypertens Res | 2007 | https://conductscience.org/library/papers/18344620 | PubMed |
| 17 | 19617407 | TRPV4-dependent dilation of peripheral resistance arteries influences arterial pressure. | Am J Physiol Heart Circ Physiol | 2009 | https://conductscience.org/library/papers/19617407 | PubMed |
| 18 | 25180264 | Vascular TRP channels: performing under pressure and going with the flow. | Physiology (Bethesda) | 2014 | https://conductscience.org/library/papers/25180264 | PubMed |
| 19 | 32310696 | Origins of Hypertension in Obesity: Plain Vanilla(oid) or Multiple Flavors? | Circulation | 2020 | https://conductscience.org/library/papers/32310696 | PubMed |
| 20 | 26947561 | Increasing TRPV4 expression restores flow-induced dilation impaired in mesenteric arteries with aging. | Sci Rep | 2016 | https://conductscience.org/library/papers/26947561 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40366385 | Effects of SGLT2 inhibitors on ion channels in heart failure: focus on the endothelium. | Basic Res Cardiol | 2025 | https://conductscience.org/library/papers/40366385 | PubMed |
| 39744893 | Investigating the Role of TRPV4 and GPR35 Interaction in Endothelial Dysfunction in Aging Mice. | Aging Cell | 2025 | https://conductscience.org/library/papers/39744893 | PubMed |
| 38255767 | Role of TRP Channels in Metabolism-Related Diseases. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38255767 | PubMed |
| 37592043 | Vascular smooth muscle TRPV4 channel: a promising therapeutic target for salt-induced hypertension? | Hypertens Res | 2023 | https://conductscience.org/library/papers/37592043 | PubMed |
| 36636553 | How do phytocannabinoids affect cardiovascular health? An update on the most common cardiovascular diseases. | Ther Adv Chronic Dis | 2023 | https://conductscience.org/library/papers/36636553 | PubMed |
| 36070688 | Genetic- and diet-induced ω-3 fatty acid enrichment enhances TRPV4-mediated vasodilation in mice. | Cell Rep | 2022 | https://conductscience.org/library/papers/36070688 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CAV1 | 857 | PubTator's text mining | https://conductscience.org/library/genes/857 | NCBI Gene |
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
| NOS3 | 4846 | PubTator's text mining | https://conductscience.org/library/genes/4846 | NCBI Gene |
| TRPV4 | 59341 | PubTator's text mining | https://conductscience.org/library/genes/59341 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34616307
GET https://conductscience.org/api/papers/v1/34616307/references?page=2